Allen & Overy (A&O) advised the joint sponsors on REPT BATTERO’s global offering and listing on the Hong Kong Stock Exchange. REPT BATTERO Energy Co., Ltd....
REPT BATTERO Energy’s Listing on the HKSE
Shiyue Daotian’s HK$820.3 Million IPO
Paul Hastings advised the joint sponsors and overall coordinators in connection with Shiyue Daotian’s Hong Kong listing. Family-controlled premium rice seller, Shiyue Daotian Group Co. Ltd.’s...
ImmuneOnco Biopharmaceuticals’ HK$319 Million IPO
Cooley and JunHe advised ImmuneOnco Biopharmaceuticals on the offering, and Kirkland & Ellis and Jingtian & Gongcheng advised the joint sponsors and underwriters. ImmuneOnco Biopharmaceuticals announced...
Beisen’s Hong Kong Listing
Paul Hastings LLP advised Morgan Stanley Asia Limited and China International Capital Corporation Hong Kong Securities Limited on the deal. Morgan Stanley Asia Limited and China...
Hesai Technology’s Initial Public Offering
Fangda Partners advised the underwriters on the deal. Hesai Technology executed a $190 million IPO on NASDAQ, marking the largest Chinese IPO listed in the US capital...
Hesai Group’s Initial Public Offering
Skadden, Maples and Calder and Commerce & Finance Law Offices advised Hesai, while Fangda and Latham & Watkins advised the underwriters involved. Hesai Group was successfully...
Pagoda’s HK$442 Million Hong Kong Listing
Simpson Thacher represented Shenzhen Pagoda Industrial (Group) Corporation Ltd. Paul Hastings advised Morgan Stanley Asia Limited, as the sole sponsor, on the deal. Shenzhen Pagoda Industrial...
Super Hi’s Spin-off and Separate Listing
Kirkland & Ellis advised on Hong Kong law, Jingtian & Gongcheng advised on PRC law, Conyers Dill & Pearman advised on Cayman Islands law, Drew &...
Weilong’s US$130.3 Million Global Offering and Hong Kong Listing
Paul Hastings advised Morgan Stanley Asia Limited, China International Capital Corporation Hong Kong Securities Limited and UBS Securities Hong Kong Limited. Weilong Delicious Global Holdings Ltd....
Vertex Technology Acquisition Corporation’s Listing on the Singapore Exchange
Eng & Co and Maples and Calder acted for the issuer, while WongPartnership and Baker McKenzie represented the joint issue managers and the joint global coordinators,...
CANbridge Pharmaceuticals Inc.’s HK$604 Million IPO
Harneys, alongside Davis Polk & Wardwell and King & Wood Mallesons, acted as Cayman Islands counsel to CANbridge Pharmaceuticals Inc. Kirkland & Ellis and Tian Yuan...
HUTCHMED’s HK$ 4.17 Billion Initial Public Offering
DLA Piper advised HUTCHMED, while Linklaters and Davis Polk advised the joint sponsors and underwriters on the global offering and listing of HUTCHMED (China) Limited on...